Dimensional Fund Advisors’s Cidara Therapeutics CDTX Stock Holding History

Dimensional Fund Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-616	Closed	-$28K	–	3541
2021 Q3	$28K	Buy	+616	New	+$23.4K	﹤0.01%	3490
2021 Q2	–	Sell	-1,126	Closed	-$60K	–	3463
2021 Q1	$60K	Hold	1,126	–	–	﹤0.01%	3384
2020 Q4	$45K	Buy	1,126 +1	+0.1%	+$50	﹤0.01%	3320
2020 Q3	$64K	Sell	1,125 -80	-7%	-$5.65K	﹤0.01%	3291
2020 Q2	$89K	Hold	1,205	–	–	﹤0.01%	3283
2020 Q1	$60K	Buy	1,205 +260	+28%	+$15.6K	﹤0.01%	3309
2019 Q4	$73K	Hold	945	–	–	﹤0.01%	3332
2019 Q3	$38K	Hold	945	–	–	﹤0.01%	3392
2019 Q2	$32K	Hold	945	–	–	﹤0.01%	3441
2019 Q1	$50K	Hold	945	–	–	﹤0.01%	3413
2018 Q4	$44K	Hold	945	–	–	﹤0.01%	3405
2018 Q3	$83K	Hold	945	–	–	﹤0.01%	3373
2018 Q2	$98K	Hold	945	–	–	﹤0.01%	3303
2018 Q1	$76K	Buy	+945	New	+$129K	﹤0.01%	3300

Other funds holding CDTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dimensional Fund Advisors's CDTX Position: Q4 2021 in Review

Dimensional Fund Advisors sold out of Cidara Therapeutics (CDTX) in Q4 2021, closing a stake of 616 shares — an estimated $28K sold.

Dimensional Fund Advisors first reported a position in CDTX in Q1 2018 and held it in 14 quarters. The position peaked at $98K in Q2 2018. 53 funds tracked by Wall St. Rank hold CDTX as of Q4 2021.

Dimensional Fund Advisors reported no remaining Cidara Therapeutics position as of Q4 2021 after selling out during the quarter.
Dimensional Fund Advisors sold 616 Cidara Therapeutics shares in Q4 2021, an estimated $28K.
Dimensional Fund Advisors first reported a position in Cidara Therapeutics in Q1 2018 and held it in 14 quarters.
Dimensional Fund Advisors's Cidara Therapeutics position peaked at $98K in Q2 2018.
53 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2021.

Based on Dimensional Fund Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.